|
1
|
El-Serag HB and Rudolph KL: Hepatocellular
carcinoma: Epidemiology and molecular carcinogenesis.
Gastroenterology. 1329:2557–2576. 2007. View Article : Google Scholar
|
|
2
|
Asia-Pacific Working Party on Prevention
of Hepatocellular Carcinoma. Prevention of hepatocellular carcinoma
in the Asia-Pacific region: consensus statements. J Gastroenterol
Hepatol. 25:657–663. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
International Agency for Research on
Cancer. GLOBOCAN. 2008, Geneva: WHO. Available at http://www-dep.iarc.fr/.
|
|
4
|
Mori M, Hara M, Wada I, Hara I, Yamamoto
K, Honda M and Naramoto J: Prospective study of hepatitis B and C
viral infections, cigarette smoking, alcohol consumption, and other
factors associated with hepatocellular carcinoma risk in Japan. Am
J Epidemiol. 151:131–139. 2000. View Article : Google Scholar
|
|
5
|
Yuan JM, Govindarajan S, Arakawa K and Yu
MC: Synergism of alcohol, diabetes, and viral hepatitis on the risk
of hepatocellular carcinoma in blacks and whites in the U.S.
Cancer. 101:1009–1017. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jee SH, Ohrr H, Sull JW and Samet JM:
Cigarette smoking, alcohol drinking, hepatitis B, and risk for
hepatocellular carcinoma in Korea. J Natl Cancer Inst.
96:1851–1856. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kuper H, Tzonou A, Kaklamani E, et al:
Tobacco smoking, alcohol consumption and their interaction in the
causation of hepatocellular carcinoma. Int J Cancer. 85:498–502.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Marrero JA, Fontana RJ, Fu S, Conjeevaram
HS, Su GL and Lok AS: Alcohol, tobacco and obesity are synergistic
risk factors for hepatocellular carcinoma. J Hepatol. 42:218–224.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhang JY, Dai M, Wang X, et al: A
case-control study of hepatitis B and C virus infection as risk
factors for hepatocellular carcinoma in Henan, China. Int J
Epidemiol. 27:574–578. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang JY, Wang X, Han SG and Zhuang H: A
case-control study of risk factors for hepatocellular carcinoma in
Henan, China. Am J Trop Med Hyg. 59:947–951. 1998.PubMed/NCBI
|
|
11
|
Budhu A and Wang XW: The role of cytokines
in hepatocellular carcinoma. J Leukoc Biol. 80:1197–1213. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Giacalone A, Montalto G, Giannitrapani L,
et al: Association between single nucleotide polymorphisms in the
cyclooxygenase-2, tumor necrosis factor-α, and vascular endothelial
growth factor-A genes, and susceptibility to hepatocellular
carcinoma. OMICS. 15:193–196. 2011.
|
|
13
|
Li S, Deng Y, Chen ZP, et al: Genetic
polymorphism of interleukin-16 influences susceptibility to
HBV-related hepatocellular carcinoma in a Chinese population.
Infect Genet Evol. 11:2083–2088. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chinen MH, Yeh CB, Li YC, et al:
Relationship of interleukin-8 gene polymorphisms with
hepatocellular carcinoma susceptibility and pathological
development. J Surg Oncol. 104:798–803. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sümbül AT, Akkiz H, Bayram S, Bekar A,
Akqöllü E and Sandıkçı M: p53 codon 72 polymorphism is associated
with susceptibility to hepatocellular carcinoma in the Turkish
population: a case-control study. Mol Biol Rep. 39:1639–1647.
2012.PubMed/NCBI
|
|
16
|
Chakravarti A: Population genetics -
making sense out of sequence. Nat Genet. 21:56–60. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ikeda M, Iwata N, Kitajima T, Suzuki T,
Yamanouchi Y, Kinoshita Y and Ozaki N: Positive association of the
serotonin 5-HT7 receptor gene with schizophrenia in a Japanese
population. Neuropsychopharmacology. 31:866–871. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
The International HapMap Consortium. A
haplotype map of the human genome. Nature. 437:1299–1320. 2005.
View Article : Google Scholar
|
|
19
|
International HapMap Consortium. Frazer
KA, Ballinqer DG, et al: A second generation human haplotype map of
over 3.1 million SNPs. Nature. 449:851–861. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
de Bakker PI, Burtt NP, Graham RR, et al:
Transferability of tag SNPs in genetic association studies in
multiple populations. Nat Genet. 38:1298–1303. 2006.PubMed/NCBI
|
|
21
|
Soo Hoo L, Zhang JY and Chan EK: Cloning
and characterization of a novel 90 kDa ‘companion’ auto-antigen of
p62 overexpressed in cancer. Oncogene. 21:5006–5015. 2002.
|
|
22
|
Zhang JY, Wang X, Peng XX and Chan EK:
Autoantibody responses in Chinese hepatocellular carcinoma. J Clin
Immunol. 22:98–105. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Junttila MR, Puustinen P, Niemelä M, et
al: CIP2A inhibits PP2A in human malignancies. Cell. 130:51–62.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ye S, Dhillon S, Ke X, Collins AR and Dav
IN: An efficient procedure for genotyping single nucleotide
polymorphisms. Nucleic Acids Res. 29:E88–8. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Little S: Amplification-refractory
mutation system (ARMS) analysis of point mutations. Curr Protoc Hum
Genet. Chapter 9(Unit 9): 82001.PubMed/NCBI
|
|
26
|
Rothman KJ: The estimation of synergy or
antagonism. Am J Epidemiol. 103:506–511. 1976.PubMed/NCBI
|
|
27
|
Han W, Kang D, Lee JE, et al: A haplotype
analysis of HER-2 gene polymorphisms: association with breast
cancer risk, HER-2 protein expression in the tumor, and disease
recurrence in Korea. Clin Cancer Res. 11:4775–4778. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hu Z, Xu L, Shao M, et al: Polymorphisms
in the two helicases ERCC2/XPD and ERCC3/XPB of the transcription
factor IIH complex and risk of lung cancer: a case-control analysis
in a Chinese population. Cancer Epidemiol Biomarkers Prev.
15:1336–1340. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kirk GD, Bah E and Montesano R: Molecular
epidemiology of human liver cancer: insights into etiology,
pathogenesis and prevention from The Gambia, West Africa.
Carcinogenesis. 27:2070–2082. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Brechot C, Kremsdorf D, Soussan P, Pineau
P, Dejean A, Paterlini-Brechot P and Tiollais P: Hepatitis B virus
(HBV)-related hepatocellular carcinoma (HCC): molecular mechanisms
and novel paradigms. Pathol Biol (Paris). 58:278–287. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Koike K: Hepatitis C virus contributes to
hepatocarcinogenesis by modulating metabolic and intracellular
signaling pathways. J Gastroenterol Hepatol. 22:S108–S111. 2007.
View Article : Google Scholar : PubMed/NCBI
|
